HR-positive/HER2-negative is the most common subtype of breast cancer in women. HR-positive/HER2-negative metastatic breast ...

HER2-negative and HER2-positive are types of breast cancer that share some things in common but have plenty of differences, too. Which kind you have can affect the treatment you get.

During a live event, Heather L. McArthur, MD, MPH, discussed the TAILORx trial in node-negative hormone ...

DelveInsight's HER2-low Cancers Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, emerging HER2-low ...

Panelists highlight that oral endocrine therapies for hormone receptor-positive breast cancer are generally well tolerated ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic breast cancer should know.

HER2-positive breast cancer is a fast-growing type. Learn about its symptoms, causes, treatment, and prevention options. Early detection and targeted therapy can lead to a cure.

What is HER2+ breast cancer? According to the American Cancer Society, about 15% to 20% (or 1 of every 5) of breast tumors have higher levels of a protein known as HER2.These cancers are called ...

HER2-negative breast cancer is characterized by the absence of the HER2 protein. Learn the symptoms, risk factors, diagnosis, prognosis, and treatment options.

Breast cancer patients may have inferior recurrence-free survival after neoadjuvant chemotherapy if they are overweight or obese at diagnosis.

If your HER2-negative cancer goes away, then comes back or spreads, your doctor may test it again to see if it’s still negative for HER2. Treatments for HER2-Negative Breast Cancer.